TSXV:CLAS.H - Post by User
Comment by
Jmk2454on Jun 27, 2019 6:38am
67 Views
Post# 29868506
RE:People keep talking about buyouts
RE:People keep talking about buyoutsExactly - they are not looking to be bought out. The news release on May 21 states:
“As previously discussed, the business strategy we are pursuing for our GVHD products is to out-license the commercial rights for these products after we have completed the ongoing Phase 2 study in prevention of GVHD,” stated Robert Farrell, President and CEO of Kalytera. “Consistent with this strategy, and based on the fact that we have already received unsolicited inquiries regarding the rights to these products, we have chosen to engage Echelon to determine the current risk adjusted value of these products, and to assist us in managing the process for identifying the optimum corporate partner or partners who may assist with some or all further costs for development of these products, such as the costs for Phase 3 clinical testing. Echelon will also assist Kalytera in evaluating any consideration that may be received by Kalytera for the commercial rights to its GVHD products, such as up-front license fees, and/or milestone payments and royalties.”
Packerfan666 wrote: People. They aren’t even entertaining being bought out. The value is in partnership and licensing not buyout. That’s a fact. They aren’t entertaining a buyout. That isn’t opinion. Mark my words. They know what they have